GlassScriptPhysician profile
Ashley Rhodes
NPI 1962852103
$1,089.29
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
See the full distribution for Adolescent Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.90 · 2020: $129 · 2021: $248 · 2022: $530 · 2023: $98.71 · 2024: $32.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $222.19 | 2020-2022 | |
| Baxter Healthcare | $99.71 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Abbvie INC. | $93.72 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $79.26 | 2022-2024 | Breztri |
| Esperion Therapeutics, INC. | $77.05 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.55 | 2022 | |
| Novartis Pharmaceuticals Corporation | $63.62 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.84 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $42.99 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.04 | 2022 | |
| Amgen INC. | $27.33 | 2019 | |
| Sobi, INC | $23.37 | 2022 | |
| Amarin Pharma, INC. | $20.40 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.21 | 2022 | |
| Glaxosmithkline, LLC. | $19.20 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $19.18 | 2022 | |
| Kaleo, INC. | $18.80 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.74 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.16 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.00 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.72 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.77 | 2019 | |
| Optos, INC. | $12.64 | 2022 | |
| Merck Sharp & Dohme LLC | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Rhodes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.